Jpmorgan Chase & CO Gh Research PLC Transaction History
Jpmorgan Chase & CO
- $1.51 Trillion
- Q3 2025
A detailed history of Jpmorgan Chase & CO transactions in Gh Research PLC stock. As of the latest transaction made, Jpmorgan Chase & CO holds 13,900 shares of GHRS stock, worth $187,650. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,900Holding current value
$187,650% of portfolio
0.0%Shares
3 transactions
Others Institutions Holding GHRS
# of Institutions
41Shares Held
38.7MCall Options Held
0Put Options Held
2.6K-
Bvf Inc San Francisco, CA8.83MShares$119 Million4.23% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.68MShares$104 Million2.05% of portfolio
-
Lynx1 Capital Management LP San Juan, PR6.75MShares$91.1 Million24.35% of portfolio
-
Rtw Investments, LP New York, NY5.54MShares$74.8 Million1.04% of portfolio
-
Cormorant Asset Management, LP Boston, MA2.01MShares$27.1 Million2.47% of portfolio
About GH Research PLC
- Ticker GHRS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,020,800
- Market Cap $702M
- Description
- GH Research PLC, a clinical-stage biopharmaceutical company, engages in developing various therapies for the treatment of psychiatric and neurological disorders. The company focuses on developing 5-Methoxy-N,N-Dimethyltryptamine (5-MeO-DMT) therapies for the treatment of patients with treatment-resistant depression (TRD). Its lead program is GH0...